These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 11417482)

  • 1. Role of splenectomy in the treatment of myelodysplastic syndromes with peripheral thrombocytopenia: a report on six cases.
    Bourgeois E; Caulier MT; Rose C; Dupriez B; Bauters F; Fenaux P
    Leukemia; 2001 Jun; 15(6):950-3. PubMed ID: 11417482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide for the treatment of patients with myelodysplastic syndromes.
    Strupp C; Germing U; Aivado M; Misgeld E; Haas R; Gattermann N
    Leukemia; 2002 Jan; 16(1):1-6. PubMed ID: 11840256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of 76 patients with myelodysplastic syndromes treated with danazol.
    Chabannon C; Molina L; Pégourié-Bandelier B; Bost M; Léger J; Hollard D
    Cancer; 1994 Jun; 73(12):3073-80. PubMed ID: 8200005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation for the presence of anti-erythropoietin antibodies in patients with myelodysplastic syndromes.
    Voulgari PV; Hatzimichael EC; Tsiara S; Tzallas C; Drosos AA; Bourantas KL
    Eur J Haematol; 2001 Jan; 66(1):31-6. PubMed ID: 11168505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous and cytokine-induced thrombocytopenia in myelodysplastic syndromes: serum thrombopoietin levels and bone marrow morphology. Scandinavian MDS Group, Sweden and Norway.
    Hellström-Lindberg E; Kanter-Lewensohn L; Nichol J; Ost A
    Br J Haematol; 1999 Jun; 105(4):966-73. PubMed ID: 10554808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenic histopathological patterns in chronic myelomonocytic leukemia with clinical correlations: reinforcement of the heterogeneity of the syndrome.
    Steensma DP; Tefferi A; Li CY
    Leuk Res; 2003 Sep; 27(9):775-82. PubMed ID: 12804634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Splenectomy can cure thrombocytopenia of systemic lupus erythematosus].
    Raguin G; Lê Thi Huong D; Piette JC; Bletry O; Renou P; Guillevin L; Langlois P; Godeau P
    Presse Med; 1989 Oct; 18(35):1739-42. PubMed ID: 2531388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial.
    Mittelman M; Platzbecker U; Afanasyev B; Grosicki S; Wong RSM; Anagnostopoulos A; Brenner B; Denzlinger C; Rossi G; Nagler A; Garcia-Delgado R; Portella MSO; Zhu Z; Selleslag D
    Lancet Haematol; 2018 Jan; 5(1):e34-e43. PubMed ID: 29241762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum erythropoietin (EPO) levels correlate with survival and independently predict response to EPO treatment in patients with myelodysplastic syndromes.
    Wallvik J; Stenke L; Bernell P; Nordahl G; Hippe E; Hast R
    Eur J Haematol; 2002 Mar; 68(3):180-5. PubMed ID: 12068800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial.
    Platzbecker U; Wong RS; Verma A; Abboud C; Araujo S; Chiou TJ; Feigert J; Yeh SP; Götze K; Gorin NC; Greenberg P; Kambhampati S; Kim YJ; Lee JH; Lyons R; Ruggeri M; Santini V; Cheng G; Jang JH; Chen CY; Johnson B; Bennett J; Mannino F; Kamel YM; Stone N; Dougherty S; Chan G; Giagounidis A
    Lancet Haematol; 2015 Oct; 2(10):e417-26. PubMed ID: 26686043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Danazol therapy in myelodysplasia.
    Cines DB; Cassileth PA; Kiss JE
    Ann Intern Med; 1985 Jul; 103(1):58-60. PubMed ID: 4003989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Danazol for the treatment of refractory autoimmune thrombocytopenia in systemic lupus erythematosus.
    West SG; Johnson SC
    Ann Intern Med; 1988 May; 108(5):703-6. PubMed ID: 3358571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Danazol treatment of myelodysplastic syndromes.
    Stadtmauer EA; Cassileth PA; Edelstein M; Abrahm J; Schreiber AD; Nowell PC; Cines DB
    Br J Haematol; 1991 Apr; 77(4):502-8. PubMed ID: 1827346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eltrombopag for myelodysplastic syndromes or chronic myelomonocytic leukaemia with no excess blasts and thrombocytopenia: a French multicentre retrospective real-life study.
    Comont T; Meunier M; Cherait A; Santana C; Cluzeau T; Slama B; Laribi K; Giraud JT; Dimicoli S; Berceanu A; Le Clech L; Cony-Makhoul P; Gruson B; Torregrosa J; Sanhes L; Jachiet V; Azerad MA; Al Jijakli A; Gyan E; Gaudin C; Broner J; Guerveno C; Guillaume T; Ades PL; Beyne-Rauzy O; Fenaux P;
    Br J Haematol; 2021 Jul; 194(2):336-343. PubMed ID: 34151423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme.
    van der Helm LH; Alhan C; Wijermans PW; van Marwijk Kooy M; Schaafsma R; Biemond BJ; Beeker A; Hoogendoorn M; van Rees BP; de Weerdt O; Wegman J; Libourel WJ; Luykx-de Bakker SA; Minnema MC; Brouwer RE; Croon-de Boer F; Eefting M; Jie KS; van de Loosdrecht AA; Koedam J; Veeger NJ; Vellenga E; Huls G
    Br J Haematol; 2011 Dec; 155(5):599-606. PubMed ID: 21981697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor.
    Hofmann WK; Ganser A; Seipelt G; Ottmann OG; Zander C; Geissler G; Hoffmann K; Höffken K; Fischer JT; Isele G; Hoelzer D
    Ann Hematol; 1999 Mar; 78(3):125-30. PubMed ID: 10211754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes.
    Molldrem JJ; Leifer E; Bahceci E; Saunthararajah Y; Rivera M; Dunbar C; Liu J; Nakamura R; Young NS; Barrett AJ
    Ann Intern Med; 2002 Aug; 137(3):156-63. PubMed ID: 12160363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen therapy in myelodysplastic syndromes with thrombocytopenia: a report on 20 cases.
    Wattel E; Cambier N; Caulier MT; Sautière D; Bauters F; Fenaux P
    Br J Haematol; 1994 May; 87(1):205-8. PubMed ID: 7947249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of topotecan single-agent therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Beran M; Estey E; O'Brien SM; Giles FJ; Koller CA; Kornblau S; Keating M; Kantarjian HM
    Leuk Lymphoma; 1998 Nov; 31(5-6):521-31. PubMed ID: 9922042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin A in myelodysplastic syndrome: a preliminary report.
    Dixit A; Chatterjee T; Mishra P; Choudhary DR; Mahapatra M; Saxena R; Choudhry VP
    Ann Hematol; 2005 Sep; 84(9):565-8. PubMed ID: 15809884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.